Drug Approval | March 27, 2023
Briefs: Morepen Laboratories and Zydus Lifesciences
The company is addressing these observations
The company is addressing these observations
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The audit is a pre-approval inspection for three products filed from the facility
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10 mg market achieved annual sales of approximately US $26.9 million
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Biocorp will receive an initial milestone payment this year
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Subscribe To Our Newsletter & Stay Updated
